PD
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Domains and categories of needs in long-term follow-up of adult cancer survivors : a scoping review of systematic reviews | Healthcare | 2024 | 32 | 38 | |||
Experiences and Needs of Swiss Cancer Survivors in the Domains of Health-Related Information and the Healthcare System | Cancers | 2024 | 17 | 14 | |||
Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study | Cancer | 2024 | 121 | 24 | |||
Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | 2024 | 68 | 22 | |||
Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon : a retrospective study | Swiss medical weekly | 2023 | 33 | 16 | |||
Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics | International journal of cancer | 2023 | 410 | 49 | |||
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | 2023 | 262 | 53 | |||
Cancer vaccines | Cancer cell | 2022 | 233 | 97 | |||
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | 2022 | 199 | 59 | |||
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised | Nature reviews. Neuroscience | 2022 | 132 | 1 | |||
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer | iScience | 2022 | 186 | 90 | |||
Hyaline cartilage microtissues engineered from adult dedifferentiated chondrocytes: safety and role of WNT signaling | Stem cells translational medicine | 2022 | 286 | 93 | |||
Linking unfolded protein response to ovarian cancer cell fusion | BMC cancer | 2022 | 209 | 125 | |||
The first comprehensive genomic characterization of rectal squamous cell carcinoma | Journal of gastroenterology | 2022 | 145 | 58 | |||
Modeling poliovirus infection using human engineered neural tissue enriched with motor neuron derived from embryonic stem cells | Frontiers in Cell and Developmental Biology | 2021 | 320 | 89 | |||
SARS-CoV-2 Evolution among Oncological Population: In-Depth Virological Analysis of a Clinical Cohort | Microorganisms | 2021 | 148 | 82 | |||
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy | Science Immunology | 2021 | 379 | 883 | |||
Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread | Neurology Genetics | 2021 | 290 | 62 | |||
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer | Cancer Cell | 2021 | 228 | 208 | |||
Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin) | JCI insight | 2021 | 212 | 54 | |||
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | 2021 | 296 | 182 | |||
Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm? | Cancer treatment reviews | 2021 | 46 | 25 | |||
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | 2020 | 389 | 161 | |||
An experimentally defined hypoxia gene signature in glioblastoma and its modulation by metformin | Biology (Basel)[2079-7737] | 2020 | 431 | 263 | |||
Journée du cancer : mobiliser autour de la prévention | Revue médicale suisse | 2020 | 207 | 109 | |||
Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma | Transplantation | 2020 | 296 | 244 | |||
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma | OncoImmunology | 2020 | 344 | 251 | |||
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients | Frontiers in Oncology | 2020 | 286 | 100 | |||
Oncologie : naviguer la pandémie de COVID-19 et garder le cap | Revue médicale suisse | 2020 | 214 | 73 | |||
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool | Health Science Reports | 2020 | 163 | 126 | |||
Une période de craintes et de défis : vers un monde meilleur ? | Revue médicale suisse | 2020 | 186 | 0 | |||
Stratégies de vaccination thérapeutique dans le glioblastome | Medecine Sciences | 2020 | 184 | 288 | |||
Resources-stratified guidelines for classical hodgkin lymphoma | International Journal of Environmental Research and Public Health | 2020 | 360 | 145 | |||
Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma | Cancers | 2020 | 296 | 157 | |||
Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma | Molecular and Cellular Proteomics | 2019 | 390 | 2 | |||
De sérieuses préoccupations qui ne cachent pas nos espoirs | Revue médicale suisse | 2019 | 268 | 88 | |||
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients | Neuro-Oncology | 2019 | 759 | 373 | |||
Current strategies for vaccination in glioblastoma | Current Opinion in Oncology | 2019 | 369 | 5 | |||
Peptides as cancer vaccines | Current Opinion in Pharmacology | 2019 | 381 | 4 | |||
Actively personalized vaccination trial for newly diagnosed glioblastoma | Nature | 2019 | 514 | 12 | |||
Exploratory study of the effect of IMA950/poly-ICLC vaccination on response to bevacizumab in relapsing high-grade glioma patients | Cancers | 2019 | 338 | 158 | |||
Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma | Scientific Reports | 2019 | 232 | 808 | |||
Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End Point | Journal of Clinical Oncology | 2018 | 429 | 1 | |||
CAR T-Cell Therapies in Glioblastoma: A First Look | Clinical Cancer Research | 2018 | 547 | 2 | |||
Onco-sexologie : un regard au cœur des patients | Revue médicale suisse | 2018 | 267 | 104 | |||
De vrais espoirs et de sérieuses préoccupations | Revue médicale suisse | 2018 | 306 | 2 | |||
Learning from the past to design better trials in second-line treatment for mesothelioma patients | Ecancermedicalscience | 2018 | 307 | 110 | |||
Médecine sexuelle et cancers : une main tendue vers l'humain | Revue médicale suisse | 2018 | 331 | 154 | |||
Diagnosis and treatment of follicular lymphoma: an update | Swiss Medical Weekly | 2018 | 538 | 267 | |||
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors | The Journal of Pathology | 2018 | 852 | 6 | |||
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma | Molecular and Cellular Proteomics | 2018 | 399 | 2 | |||
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models | OncoImmunology | 2018 | 378 | 1 | |||
Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists | Canadian Journal of Cardiology | 2018 | 495 | 2 | |||
« Docteur, je jeûne lors de la chimiothérapie » : illusion ou nouvelle réalité clinique ? | Revue médicale suisse | 2018 | 577 | 436 | |||
Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland | Swiss Medical Weekly | 2018 | 531 | 180 | |||
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma | OncoImmunology | 2018 | 624 | 275 | |||
Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy | Nutrition and Cancer | 2018 | 428 | 386 | |||
Prise en charge de la sexualité chez les patients oncologiques: Un projet de recherche au sein des Hôpitaux universitaires de Genève | Revue médicale suisse | 2018 | 343 | 186 | |||
BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma | Neurology | 2017 | 512 | 185 | |||
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies | OncoImmunology | 2017 | 595 | 9 | |||
A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells | Oncotarget | 2017 | 494 | 170 | |||
Les cancers s'envolent, les progrès suivent | Tribune de Geneve | 2017 | 357 | 54 | |||
Immunothérapie des gliomes : illusion ou espoir ? | Bulletin du cancer | 2017 | 381 | 0 | |||
Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancer | Digestive and Liver Disease | 2017 | 495 | 0 | |||
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial | The Lancet Oncology | 2017 | 365 | 1 | |||
Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports | 2017 | 548 | 4 | |||
ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells | EMBO Journal | 2017 | 571 | 10 | |||
8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016 | Drug Metabolism and Personalized Therapy | 2017 | 517 | 3 | |||
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients | British Journal of Haematology | 2017 | 415 | 0 | |||
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma | Cancer Cell | 2017 | 470 | 5 | |||
L'accès à l'innovation | Revue médicale suisse | 2017 | 321 | 0 | |||
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? | Frontiers in Oncology | 2016 | 476 | 392 | |||
Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness | Biomaterials | 2016 | 526 | 5 | |||
Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes | Journal of neuro-oncology | 2016 | 484 | 415 | |||
Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis | Cancer medicine | 2016 | 536 | 179 | |||
Cell-penetrating peptides-the Swiss Army knife of cancer vaccines | Oncoimmunology | 2016 | 597 | 271 | |||
Progrès dans l'immunothérapie des tumeurs cérébrales : difficultés et perspectives | Revue médicale suisse | 2016 | 316 | 2 | |||
Medulloblastoma in children and adults: one distinct disease entity? | Bulletin suisse du cancer | 2016 | 456 | 48 | |||
Hypoxia and antitumor CD8(+) T cells: An incompatible alliance? | OncoImmunology | 2016 | 447 | 256 | |||
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing | PloS one | 2016 | 567 | 597 | |||
Ipilimumab-related hypophysitis may precede severe CNS immune attack | Annals of Oncology | 2016 | 435 | 0 | |||
Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants | Molecular therapy | 2016 | 628 | 283 | |||
Chimiothérapie de maintenance : futile ou utile ? | Revue médicale suisse | 2015 | 450 | 157 | |||
Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit | Supportive care in cancer | 2015 | 648 | 1 | |||
Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells | European Journal of Immunology | 2015 | 509 | 7 | |||
Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review | CNS oncology | 2015 | 470 | 0 | |||
Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity | Cancer research | 2015 | 585 | 10 | |||
La société face au cancer : prises de conscience et initiatives citoyennes | Revue médicale suisse | 2015 | 349 | 69 | |||
Lymphome cérébral : une présentation classique ? | Revue médicale suisse | 2015 | 352 | 375 | |||
Immunotherapy of Brain Tumors | Progress in tumor research | 2015 | 541 | 0 | |||
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome | Annals of oncology | 2015 | 428 | 149 | |||
Création du Centre du cancer de la prostate des HUG | Revue médicale suisse | 2014 | 687 | 2 | |||
Immunotherapy for glioma: from illusion to realistic prospects? | American Society of Clinical Oncology educational book | 2014 | 1,214 | 562 | |||
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma | British journal of cancer | 2014 | 529 | 151 | |||
Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response | International journal of cancer | 2014 | 699 | 391 | |||
Extrachromosomal driver mutations in glioblastoma and low-grade glioma | Nature communications | 2014 | 706 | 189 | |||
Fine-needle aspiration biopsy for the diagnosis of metastatic type B thymoma to lymph nodes: A case report | Diagnostic cytopathology | 2014 | 599 | 0 | |||
Injecting hope into brain cancer treatment: is immunotherapy the way forward? | CNS Oncology | 2014 | 358 | 0 | |||
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) | European urology | 2013 | 557 | 0 | |||
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients | Clinical & developmental immunology | 2013 | 568 | 554 | |||
Neuropathies associées aux paraprotéinémies (gammapathies monoclonales) | Revue médicale suisse | 2013 | 405 | 0 | |||
Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours | PloS one | 2013 | 668 | 305 | |||
The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma | Biomaterials | 2013 | 677 | 6 | |||
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy | Journal of neuro-oncology | 2013 | 611 | 0 | |||
Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies | Immunotherapy | 2013 | 501 | 0 | |||
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival | Nature medicine | 2012 | 532 | 2 | |||
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status | Acta neuropathologica | 2012 | 537 | 1,017 | |||
Plasmablastic lymphoma clinically presenting in the urinary tract | Annals of diagnostic pathology | 2012 | 628 | 0 | |||
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma | Haematologica | 2012 | 553 | 438 | |||
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy | Brain | 2012 | 648 | 1,290 | |||
Complete remission with tyrosine kinase inhibitors in renal cell carcinoma | Journal of clinical oncology | 2012 | 707 | 718 | |||
Visceral Kaposi's Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature Review | Case reports in oncological medicine | 2012 | 595 | 279 | |||
Takotsubo syndrome secondary to adrenal adenocarcinoma: cortisol as a possible culprit | American journal of respiratory and critical care medicine | 2012 | 624 | 5 | |||
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients | The oncologist | 2012 | 637 | 0 | |||
Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis | Case reports in oncology | 2011 | 627 | 0 | |||
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 987 | 569 | |||
Soin nutritionnel intégré au soin oncologique : un besoin d'optimisation | Revue médicale suisse | 2011 | 928 | 722 | |||
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 833 | 8 | |||
Prevention of CNS relapse in diffuse large B-cell lymphoma | Lancet oncology | 2011 | 530 | 0 | |||
Recurrent Syncope due to Esophageal Squamous Cell Carcinoma | Case reports in oncology | 2011 | 653 | 273 | |||
Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report | Journal of medical case reports | 2011 | 589 | 156 | |||
Oncology ESAB 2011 | 2011 | 617 | 10 | ||||
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma | GLIA | 2010 | 649 | 0 | |||
Marker-independent identification of glioma-initiating cells | Nature methods | 2010 | 503 | 0 | |||
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98 | Journal of clinical oncology | 2010 | 498 | 0 | |||
Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development | Cancer research | 2010 | 575 | 3 | |||
T-cell immunotherapy for malignant glioma: toward a combined approach | Current opinion in oncology | 2010 | 629 | 2 | |||
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma | Journal of clinical oncology | 2010 | 569 | 0 | |||
Tumors that look for their springtime in APRIL | Critical reviews in oncology/hematology | 2009 | 622 | 0 | |||
Limits of CD133 as a marker of glioma self-renewing cells | International journal of cancer | 2009 | 588 | 0 | |||
Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant | Journal of immunotherapy | 2009 | 573 | 0 | |||
Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital | British journal of cancer | 2009 | 606 | 0 | |||
Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error? | Blood | 2009 | 519 | 1 | |||
Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva) | Dermatology | 2008 | 513 | 0 | |||
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma | Journal of clinical oncology | 2008 | 649 | 0 | |||
Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants : résultats préliminaires d'une étude multicentrique de l'Anocef | Revue neurologique | 2008 | 623 | 0 | |||
Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome | Annals of oncology | 2008 | 565 | 0 | |||
Percutaneous cementoplasty in multiple myeloma: a valuable adjunct for pain control and ambulation maintenance | Supportive care in cancer | 2008 | 578 | 257 | |||
Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes | GLIA | 2008 | 600 | 11 | |||
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers | Annals of oncology | 2008 | 520 | 0 | |||
Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system | World journal of surgical oncology | 2008 | 1,123 | 515 | |||
Bortezomib-induced skin eruption | Dermatology | 2008 | 561 | 0 | |||
Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas | Journal of pathology | 2006 | 600 | 0 | |||
Cytomegalovirus colitis--a severe complication after standard chemotherapy | Acta oncologica | 2002 | 587 | 0 |